Literature DB >> 19805565

Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.

Qiwen Yang1, Hui Wang, Hongli Sun, Hongbin Chen, Yingchun Xu, Minjun Chen.   

Abstract

The resistance mechanism of 49 Enterobacteriaceae isolates with decreased susceptibility to carbapenems collected from 2004 to 2008 at 16 teaching hospitals in China was investigated. Moderate- to high-level carbapenem resistance in most isolates was more closely associated with loss or decreased expression of both major porins combined with production of AmpC or extended-spectrum beta-lactamase enzymes, while KPC-2, IMP-4, and IMP-8 carbapenemase production may lead to a low to moderate level of carbapenem resistance in Enterobacteriaceae in China.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19805565      PMCID： PMC2798477          DOI： 10.1128/AAC.01099-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Porin expression in clinical isolates of Klebsiella pneumoniae.

Authors:  Santiago Hernández-Allés; Sebastián Albertí; Dolores Álvarez; Antonio Doménech-Sánchez; Luis Martínez-Martínez; José Gil; Juan M Tomás; Vicente J Benedí
Journal:  Microbiology       Date:  1999-03       Impact factor: 2.777

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

5.  Transferable DHA-1 cephalosporinase in Escherichia coli.

Authors:  P Giakkoupi; A Tambic-Andrasevic; S Vourli; J Skrlin; S Sestan-Crnek; L S Tzouvelekis; A C Vatopoulos
Journal:  Int J Antimicrob Agents       Date:  2005-12-13       Impact factor: 5.283

6.  Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production.

Authors:  L Armand-Lefèvre; V Leflon-Guibout; J Bredin; F Barguellil; A Amor; J M Pagès; M-H Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

7.  PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron.

Authors:  Naohiro Shibata; Yohei Doi; Kunikazu Yamane; Tetsuya Yagi; Hiroshi Kurokawa; Keigo Shibayama; Haru Kato; Kumiko Kai; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  PCR mapping of integrons reveals several novel combinations of resistance genes.

Authors:  C Lévesque; L Piché; C Larose; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.

Authors:  Jia Chang Cai; Hong Wei Zhou; Rong Zhang; Gong-Xiang Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

10.  Emergence of imipenem resistance in clinical Escherichia coli during therapy.

Authors:  Jesús Oteo; Alberto Delgado-Iribarren; Dolores Vega; Verónica Bautista; María Cruz Rodríguez; María Velasco; José María Saavedra; María Pérez-Vázquez; Silvia García-Cobos; Luis Martínez-Martínez; José Campos
Journal:  Int J Antimicrob Agents       Date:  2008-09-04       Impact factor: 5.283
View more
  28 in total

1.  Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.

Authors:  Athanassios Tsakris; Katerina Themeli-Digalaki; Aggeliki Poulou; Georgia Vrioni; Evangelia Voulgari; Vasiliki Koumaki; Antonella Agodi; Spyros Pournaras; Danai Sofianou
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

2.  Characterization of a novel Klebsiella pneumoniae sequence type 476 carrying both bla KPC-2 and bla IMP-4.

Authors:  Y Wang; W Cao; X Zhu; Z Chen; L Li; B Zhang; B Wang; L Tian; F Wang; C Liu; Z Sun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-21       Impact factor: 3.267

3.  Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.

Authors:  Q Wang; Y Zhang; X Yao; H Xian; Y Liu; H Li; H Chen; X Wang; R Wang; C Zhao; B Cao; H Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-11       Impact factor: 3.267

4.  Characteristics and management of Enterobacteriaceae harboring IMP-4 or IMP-8 carbapenemase in a tertiary hospital.

Authors:  Feng Pang; Xiu-Qin Jia; Zhen-Zhu Song; Yan-Hua Li; Bin Wang; Qi-Gang Zhao; Chuan-Xin Wang; Yi Zhang; Le-Xin Wang
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

5.  Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.

Authors:  Yawei Zhang; Qi Wang; Yuyao Yin; Hongbin Chen; Longyang Jin; Bing Gu; Liangyi Xie; Chunxia Yang; Xiaobo Ma; Huayin Li; Wei Li; Xiaoqian Zhang; Kang Liao; Sijin Man; Shifu Wang; Hainan Wen; Binbin Li; Zhusheng Guo; Jinjing Tian; Fengyan Pei; Li Liu; Lijun Zhang; Cuimei Zou; Tongping Hu; Jun Cai; Hong Yang; Jiaming Huang; Xianghong Jia; Wenhui Huang; Bin Cao; Hui Wang
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

6.  Mechanism for carbapenem resistance of clinical Enterobacteriaceae isolates.

Authors:  Yafei Ye; Lijuan Xu; Yanping Han; Zhe Chen; Cailin Liu; Liang Ming
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

7.  Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China.

Authors:  Douglas M Warner; Qiwen Yang; Valérie Duval; Minjun Chen; Yingchun Xu; Stuart B Levy
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

8.  Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.

Authors:  Wil H F Goessens; Akke K van der Bij; Ria van Boxtel; Johann D D Pitout; Peter van Ulsen; Damian C Melles; Jan Tommassen
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

Review 9.  Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy.

Authors:  Constance Schultsz; Suzanne Geerlings
Journal:  Drugs       Date:  2012-01-01       Impact factor: 11.431

10.  Characterization of carbapenemase genes in Enterobacteriaceae species exhibiting decreased susceptibility to carbapenems in a university hospital in Chongqing, China.

Authors:  Yun Xia; Zhenzhen Liang; Xiaoyan Su; Ying Xiong
Journal:  Ann Lab Med       Date:  2012-06-20       Impact factor: 3.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.